Nurix Therapeutics Inc share price logo

Nurix Therapeutics Inc Share Price

NASDAQ: NRIX

Small Cap

$8.66

-0.38

(-4.20%)

as on

Nurix Therapeutics Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $8.59
    $9.12
    downward going graph

    0.81%

    Downside

    5.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.18
    $29.56
    downward going graph

    5.54%

    Downside

    241.34%

    Upside

    downward going graph

Nurix Therapeutics Inc share price movements today

Previous Close
$9.04
Open
$9.09
Volume
1.2M
Day's Low - High
$8.59 - $9.12
52 Week Low - High
$8.18 - $29.56

Nurix Therapeutics Inc Historical Returns

1 Month Return
-15.41 %
3 Month Return
-24.98 %
1 Year Return
-63.91 %
3 Year Return
-45.33 %
5 Year Return
-69.78 %

Nurix Therapeutics Inc Stock Fundamentals & Key Indicators

Check Nurix Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$691.1M

EPS (TTM)

-2.9638

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-9.76

Industry PE ratio

0.41889261744966444

P/B Ratio

0

PEG Ratio

0

EBITDA

-222.2M

Revenue (TTM)

88.4M

Profit Margin

-234.57%

Return On Equity TTM

79205500.00%

Nurix Therapeutics Inc Stock Valuation

Track how Nurix Therapeutics Inc P/E has moved over time to understand its valuation trends.

Nurix Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Today (-9.76x)

September 15, 2025

Industry (0.42x)

September 15, 2025

Highest (0.00x)

September 15, 2025

LowHigh

Today’s Price to Earnings Ratio: -9.76x

Nurix Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nurix Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$691.1M-69.78%-9.76-234.57%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Nurix Therapeutics Inc Stock including INR - Dollar returns

The Nurix Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Nurix Therapeutics Inc investment value today

Current value as on today

₹39,905

Returns

₹60,095

(-60.1%)

Returns from Nurix Therapeutics Inc Stock

₹65,081 (-65.08%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Nurix Therapeutics Inc Stock

Based on 17 analysts

BUY

88.24%

Buy

11.76%

Hold

0.00%

Sell

Based on 17 analysts, 88.24% of analysts recommend a 'BUY' rating for Nurix Therapeutics Inc. Average target price of $29.83

Nurix Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Nurix Therapeutics Inc.

What analysts predicted

70.97%UPSIDE

Target Price

$29.83

Current Price

$8.66

Analyzed by

17 Analysts

Target

$29.83

Nurix Therapeutics Inc target price $29.83, a slight upside of 70.97% compared to current price of $8.66. According to 17 analysts rating.

Nurix Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Nurix Therapeutics Inc Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-38% versus previous 30 day period

Nurix Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Feb 2023
May 2023
Aug 2023
Nov 2023
Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Total Revenue
12
30
18
15
16
12
12
13
18
44
Gross Profit
9
27
15
11
12
8
4
13
18
44
Operating Income
-42
-26
-40
-45
-45
-48
-54
-64
-62
-48
EBITDA
-39
-23
-36
-41
-41
-44
-50
-60
-58
-48
Interest Expense
5
2
-
7
-
-
-
-
-
-
Depreciation
3
3
3
3
3
4
4
4
4
5
Income Before Tax
-40
-24
-36
-41
-41
-44
-48
-58
-56
-42
Income Tax Expense
-5
-2
3
7
0
0
0
0
-
0
Net Income
-35
-21
-36
-41
-41
-44
-48
-58
-56
-43
Net Profit Margin
-278.55%
-71.03%
-200.26%
-276.77%
-250.33%
-368.39%
-388.91%
-440.75%
-305.38%
-98.66%

Nurix Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Nov 2018
Nov 2019
Nov 2020
Nov 2021
Nov 2022
Nov 2023
Nov 2024
Total Revenue
37
31
17
29
38
76
54
Gross Profit
-3
-13
17
29
38
63
38
Operating Income
-9
-22
-64
-117
-183
-155
-213
EBITDA
-6
-19
-62
-111
-173
-141
-196
Interest Expense
0
0
3
6
14
-
-
Depreciation
2
2
2
6
10
13
16
Income Before Tax
-8
-21
-63
-117
-180
-143
-193
Income Tax Expense
0
0
-20
0
-14
13
0
Net Income
-9
-21
-43
-117
-166
-143
-193
Net Profit Margin
-25.18%
-69.74%
-242.66%
-393.93%
-429.87%
-186.98%
-354.85%

Nurix Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

May 2023
Aug 2023
Nov 2023
Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Net Income
-24
-36
-41
-41
-44
-48
-58
-56
-43
Operating Cash Flow
-18
-41
21
-41
-39
-42
-48
-61
-63
Investing Cash Flow
43
22
-14
35
-131
-21
-140
25
71
Financing Cash Flow
0
1
0
1
237
45
200
1
0
Change in Cash
25
-16
12
-4
66
-17
10
-34
8

Nurix Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Nov 2019
Nov 2020
Nov 2021
Nov 2022
Nov 2023
Nov 2024
Net Income
-21
-43
-117
-180
-143
-193
Operating Cash Flow
0
0
-84
-159
-81
-172
Investing Cash Flow
8
-254
-108
27
68
-257
Financing Cash Flow
0
339
153
117
3
485
Change in Cash
9
84
-38
-15
-9
55

Global Institutional Holdings in Nurix Therapeutics Inc

Funds
Holdings
FMR Inc
13.52%
BlackRock Inc
10.45%
Deep Track Capital, LP
7.19%
Vanguard Group Inc
5.78%
Redmile Group, LLC
5.3%

Insights on Nurix Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 12.09M → 44.05M (in $), with an average increase of 23.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -58.54M → -43.46M (in $), with an average increase of 16.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 72.3% return, outperforming this stock by 136.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 118.7% return, outperforming this stock by 160.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, NRIX stock has moved down by -14.6%

About Nurix Therapeutics Inc

nurix is a science-focused company that is committed to bringing novel, first-in-class therapies to patients. nurix is a leader in discovering a new class of drugs that work by modulating e3 ubiquitin ligases within the ubiquitin proteasome system (ups). the ups is a regulatory network that controls protein stabilization and degradation – a function vital to the healthy life of a cell – offering therapeutic opportunities in multiple disease areas. nurix’s scientific team has established an innovative drug discovery platform to identify selective inhibitors or activators of the ups, enabling the development of novel therapeutics that can restore normal cellular homeostasis. nurix was founded by internationally recognized experts in the ups field and received its initial funding from leading life science investors, third rock ventures and the column group. in 2015, nurix entered into a multi-year strategic collaboration with celgene to discover and develop next-generation therapies targe
OrganisationNurix Therapeutics Inc
Headquarters1700 Owens Street, San Francisco, CA, United States, 94158
IndustryHealth Technology
CEODr. Arthur T. Sands M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Nurix Therapeutics Inc

Name

Title

Mr. Johannes Van Houte

Chief Financial Officer

Dr. Christine Ring J.D., Ph.D.

Chief Legal Officer, Secretary & Chief Compliance Officer

Dr. Arthur Weiss M.D., Ph.D.

Founder & Member of Scientific Advisory Board

Rita Kwong

Senior Accounting Manager

Dr. Jason Kantor Ph.D.

Chief Business Officer

Dr. Arthur T. Sands M.D., Ph.D.

CEO, President & Director

Dr. Gwenn M. Hansen Ph.D.

Chief Scientific Officer

Dr. John Kuriyan Ph.D.

Founder & Member of Scientific Advisory Board

Dr. Pasit Phiasivongsa Ph.D.

Chief Technical Officer

Mr. Christopher B. Phelps Ph.D.

Senior VP & Head of Early Drug Discovery

FAQs

What is Nurix Therapeutics Inc share price today?

Nurix Therapeutics Inc share price today is $8.66 as on at the close of the market. Nurix Therapeutics Inc share today touched a day high of $9.12 and a low of $8.59.

What is the 52 week high and 52 week low for Nurix Therapeutics Inc share?

Nurix Therapeutics Inc share touched a 52 week high of $29.56 on and a 52 week low of $8.18 on . Nurix Therapeutics Inc stock price today i.e. is closed at $8.66,which is 70.70% down from its 52 week high and 5.87% up from its 52 week low.

What is Nurix Therapeutics Inc's market capitalisation today?

Nurix Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Nurix Therapeutics Inc Stock (NRIX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nurix Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nurix Therapeutics Inc Shares that will get you 0.1732 shares as per Nurix Therapeutics Inc share price of $8.66 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Nurix Therapeutics Inc Stock (NRIX) from India?

Indian investors can start investing in Nurix Therapeutics Inc (NRIX) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Nurix Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Nurix Therapeutics Inc share’s latest price of $8.66 as on September 16, 2025 at 1:29 am IST, you will get 1.1547 shares of Nurix Therapeutics Inc. Learn more about fractional shares .

What are the returns that Nurix Therapeutics Inc has given to Indian investors in the last 5 years?

Nurix Therapeutics Inc stock has given -69.78% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?